
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Six1 CRISPR/Cas9 KO Plasmid (m) | sc-422956 | 20 µg | $397.00 |
Six1 (sine oculis homeobox homolog 1) encodes a homeobox transcription factor that regulates embryonic patterning and organogenesis in mouse, with prominent roles in myogenesis, nephrogenesis, and sensory placode development. SIX1 coordinates lineage specification and proliferation programs through transcriptional control networks that interface with developmental signaling pathways, including interactions with EYA co-activators and modulation of growth and differentiation gene sets. Dysregulated SIX1 expression or activity is associated with aberrant developmental trajectories and has been studied in the context of congenital anomalies and oncogenic transcriptional programs. In cells, Six1-dependent transcriptional circuits influence cell-cycle progression, migration, and epithelial–mesenchymal state transitions relevant to developmental biology and disease modeling.
Six1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Six1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Six1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Six1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Six1 protein expression.
This CRISPR knockout system enables efficient generation of Six1-deficient cell models for investigation of Six1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.